Lv1
48 积分 2025-04-16 加入
Development, validation and clinical application of a LC-MS/MS method for simultaneous determination of third-generation EGFR-TKIs and metabolites in patients with NSCLC
8天前
已关闭
Development and validation of a UPLC-MS/MS method for almonertinib with its active metabolite HAS-719 and anlotinib in human plasma
12天前
已完结
Determination of cortisone and cortisol in human scalp hair using an improved LC-MS/MS-based method
27天前
已完结
Comparative Pharmacokinetics of Lutein and Zeaxanthin from Phospholipid, Liposomal, and MCT Formulations in SD Rats
1个月前
已完结
Development, validation, and clinical application of LC-MS/MS method for simultaneous determination of ibrutinib, zanubrutinib, orelabrutinib, acalabrutinib, and their active metabolites in patients with B-cell lymphoma
1个月前
已完结
“A new LC-MS/MS method for the simultaneous quantification of abemaciclib, its main active metabolites M2 and M20, and letrozole for therapeutic drug monitoring”
1个月前
已完结
Quantification of daridorexant, lemborexant and suvorexant in whole blood using liquid chromatography-tandem mass spectrometry
3个月前
已完结
Subcutaneous Semaglutide during Breastfeeding: Infant Safety Regarding Drug Transfer into Human Milk
3个月前
已完结
Development and validation of an LC-MS/MS method for Tirzepatide, a dual GIP/GLP-1 receptor agonist, in rat plasma for application to a pharmacokinetic study
3个月前
已完结
Development of a liquid chromatography-tandem mass spectrometry method for the analysis of plasma naltrexone and its active metabolite in patients with AUD
3个月前
已完结
皖公网安备34019202002308
